Castle Biosciences, Inc. (CSTL) NASDAQ
21.08
+0.96(+4.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.08
+0.96(+4.77%)
Currency In USD
| Previous Close | 20.12 |
| Open | 20.3 |
| Day High | 21.11 |
| Day Low | 20.24 |
| 52-Week High | 44.28 |
| 52-Week Low | 14.59 |
| Volume | 253,553 |
| Average Volume | 377,430 |
| Market Cap | 639.36M |
| PE | -50.19 |
| EPS | -0.42 |
| Moving Average 50 Days | 22.52 |
| Moving Average 200 Days | 28.76 |
| Change | 0.96 |
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
GlobeNewswire Inc.
Mar 09, 2026 11:00 AM GMT
Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous Melanoma Guidelines recommend avoiding a sentinel lymph node (SLN) biopsy (SLNB) if the predicted SLN positivity rate is less
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
GlobeNewswire Inc.
Mar 04, 2026 9:30 PM GMT
FRIENDSWOOD, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data evaluating DecisionDx-Melanoma’s i31-SLNB tes
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
GlobeNewswire Inc.
Mar 03, 2026 9:30 PM GMT
FRIENDSWOOD, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will host a grand opening celebration for its new c